Profile
Thaminda Ramanayake is currently Chief Executive Officer at Anaveon AG since 2026 and Venture Partner at Entree Capital since 2025.
Formerly, Mr. Ramanayake was Chief Business Officer at CureVac NV and Chief Business Officer at Affini-T Therapeutics, Inc. Education includes undergraduate studies at Berea College, graduate studies at the University of Rochester Medical Center, and an MBA from the University of Rochester Simon Business School.
Thaminda Ramanayake active positions
| Companies | Position | Start |
|---|---|---|
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Chief Executive Officer | 23/03/2026 |
Entree Capital
Entree Capital Investment ManagersFinance Entree Capital invests in companies located across the globe, primarily in Israel. The firm targets companies operating in the fields of SaaS, data, fintech, security, productivity and consumer. It provide financing for pre-seed, seed, early, later and buyout stage companies with an investment size of USD 0.25 - 3 million and also makes follow-on investments. | Private Equity Investor | 01/10/2025 |
Former positions of Thaminda Ramanayake
| Companies | Position | End |
|---|---|---|
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Corporate Officer/Principal | - |
| CUREVAC | Corporate Officer/Principal | - |
Training of Thaminda Ramanayake
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Berea College
Berea College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entree Capital
Entree Capital Investment ManagersFinance Entree Capital invests in companies located across the globe, primarily in Israel. The firm targets companies operating in the fields of SaaS, data, fintech, security, productivity and consumer. It provide financing for pre-seed, seed, early, later and buyout stage companies with an investment size of USD 0.25 - 3 million and also makes follow-on investments. | Finance |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Health Technology |
CureVac NV
CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
- Stock Market
- Insiders
- Thaminda Ramanayake
















